BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 22373583)

  • 1. Serum HE4 as a diagnostic and prognostic marker for lung cancer.
    Iwahori K; Suzuki H; Kishi Y; Fujii Y; Uehara R; Okamoto N; Kobayashi M; Hirashima T; Kawase I; Naka T
    Tumour Biol; 2012 Aug; 33(4):1141-9. PubMed ID: 22373583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Application Value of Serum HE4 in the Diagnosis of Lung Cancer.
    Wang Y; Wang Z; Ding Y; Sun F; Ding X
    Asian Pac J Cancer Prev; 2019 Aug; 20(8):2405-2407. PubMed ID: 31450913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluating the expression and diagnostic value of human epididymis protein 4 (HE4) in small cell lung cancer.
    Wang X; Fan Y; Wang J; Wang H; Liu W
    Tumour Biol; 2014 Jul; 35(7):6847-53. PubMed ID: 25051914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum Human Epididymis Secretory Protein 4 (HE4) is a Potential Prognostic Biomarker in Non-Small Cell Lung Cancer.
    Mo D; He F
    Clin Lab; 2018 Sep; 64(9):1421-1428. PubMed ID: 30274019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic Performance of Serum Human Epididymis Protein 4 (HE4) for Prediction of Malignancy in Ovarian Masses.
    Dewan R; Dewan A; Jindal M; Bhardawaj M
    Asian Pac J Cancer Prev; 2019 Apr; 20(4):1103-1108. PubMed ID: 31030480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum level of HE4 is closely associated with pulmonary adenocarcinoma progression.
    Yamashita S; Tokuishi K; Moroga T; Yamamoto S; Ohbo K; Miyahara S; Yoshida Y; Yanagisawa J; Hamatake D; Hiratsuka M; Yoshinaga Y; Shiraishi T; Iwasaki A; Kawahara K
    Tumour Biol; 2012 Dec; 33(6):2365-70. PubMed ID: 23001907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human epididymis protein 4, a novel potential biomarker for diagnostic and prognosis monitoring of lung cancer.
    Zhang T; Chu L; Tan W; Ye C; Dong H
    Clin Respir J; 2024 May; 18(5):e13774. PubMed ID: 38742362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum human epididymis protein 4 and risk for ovarian malignancy algorithm as new diagnostic and prognostic tools for epithelial ovarian cancer management.
    Bandiera E; Romani C; Specchia C; Zanotti L; Galli C; Ruggeri G; Tognon G; Bignotti E; Tassi RA; Odicino F; Caimi L; Sartori E; Santin AD; Pecorelli S; Ravaggi A
    Cancer Epidemiol Biomarkers Prev; 2011 Dec; 20(12):2496-506. PubMed ID: 22028406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HE4 combined with CA125: favorable screening tool for ovarian cancer.
    Ghasemi N; Ghobadzadeh S; Zahraei M; Mohammadpour H; Bahrami S; Ganje MB; Rajabi S
    Med Oncol; 2014 Jan; 31(1):808. PubMed ID: 24323399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human epididymal protein 4 and its combined detection show good diagnostic value in lung cancer: A retrospective study.
    Wu L; Chen X; Peng T; Tang E; Bai W; Chen L
    Int J Biol Markers; 2024 Jun; 39(2):141-148. PubMed ID: 38619974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluating the clinical significance of serum HE4 levels in lung cancer and pulmonary tuberculosis.
    Liu W; Yang J; Chi PD; Zheng X; Dai SQ; Chen H; Xu BL; Liu WL
    Int J Tuberc Lung Dis; 2013 Oct; 17(10):1346-53. PubMed ID: 24025389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significance of HE4 estimation in comparison with CA125 in diagnosis of ovarian cancer and assessment of treatment response.
    Hamed EO; Ahmed H; Sedeek OB; Mohammed AM; Abd-Alla AA; Abdel Ghaffar HM
    Diagn Pathol; 2013 Jan; 8():11. PubMed ID: 23343214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic and prognostic value of serum thioredoxin and DJ-1 in non-small cell lung carcinoma patients.
    Fan J; Yu H; Lv Y; Yin L
    Tumour Biol; 2016 Feb; 37(2):1949-58. PubMed ID: 26334622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The differential diagnostic value and clinical significance of serum HE4 in ovarian disease with elevated CA125.
    Li W; Wang D
    Arch Gynecol Obstet; 2020 May; 301(5):1219-1225. PubMed ID: 32266526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum HE4, CA125, YKL-40, bcl-2, cathepsin-L and prediction optimal debulking surgery, response to chemotherapy in ovarian cancer.
    Chudecka-Głaz AM; Cymbaluk-Płoska AA; Menkiszak JL; Sompolska-Rzechuła AM; Tołoczko-Grabarek AI; Rzepka-Górska IA
    J Ovarian Res; 2014; 7():62. PubMed ID: 25018782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum HE4: An Independent Prognostic Factor in Non-Small Cell Lung Cancer.
    Lamy PJ; Plassot C; Pujol JL
    PLoS One; 2015; 10(6):e0128836. PubMed ID: 26030627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum human epididymis protein 4 (HE4) as a tumor marker in men with lung cancer.
    Nagy B; Bhattoa HP; Steiber Z; Csobán M; Szilasi M; Méhes G; Müller M; Lázár J; Kappelmayer J; Antal-Szalmás P
    Clin Chem Lab Med; 2014 Nov; 52(11):1639-48. PubMed ID: 24829194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic accuracy of CA125 and HE4 in ovarian carcinoma patients and the effect of confounders on their serum levels.
    Ahmed AA; Abdou AM
    Curr Probl Cancer; 2019 Oct; 43(5):450-460. PubMed ID: 30670303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Triple test with tumor markers CYFRA 21.1, HE4, and ProGRP might contribute to diagnosis and subtyping of lung cancer.
    Korkmaz ET; Koksal D; Aksu F; Dikmen ZG; Icen D; Maden E; Onder S; Akbiyik F; Emri S
    Clin Biochem; 2018 Aug; 58():15-19. PubMed ID: 29729229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The clinical value of the combined detection of sEGFR, CA125 and HE4 for epithelial ovarian cancer diagnosis.
    Li Y; Wang ZC; Luo L; Mu CY; Xu J; Feng Q; Li SB; Gu B; Ma P; Lan T
    Eur Rev Med Pharmacol Sci; 2020 Jan; 24(2):604-610. PubMed ID: 32016961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.